While noting that the failure to confirm a widening of the social
gradient in hospitalization days per person-year in the diabetic
population “may result in part from low statistical power and an
overestimation of dispersion,” Icks et al. find that such a “result is
surprising, because a widening of social inequality in health is often
observed.”1
But Table 2 of their study shows that the ratio of the mean hospital
days of the low education group to that of the high education group
changed from 1.17 (3.79 over 3.24) in 1990-1992 to 1.33 (3.40 over 2.55) in
1998 or, put another way, the study found a 10 percent reduction for the
low education group compared with a 21 percent reduction for the high
education group. I assume that one would observe a similar change in
direction of the effect size between the two averages, which may be a
better approach to measurement. It is true that the change in the
difference between the two groups’ average stays was not significant. But
when one observes a change in the size of a difference that moves in an
expected direction, there is little reason to regard the mere fact that
the size of the change in the difference was not of sufficient magnitude
to be statistically significant as surprising. That is especially so when
the study is deemed to have low power. In such circumstances, it would
seem more reasonable to believe that the observed change in difference,
being in the expected direction, was more likely to reflect a real change
than to have occurred by chance.
The expectation of a widening of the social gradient raises an issue,
however. The authors cite two studies for the expectation that
socioeconomic inequalities in health are likely to widen.2,3. But each of
these authorities merely observes that certain measures of health
inequality have been widening. They do not explain why either the
measures they employ or other measures should be widening.
There is reason to expect certain measures of socioeconomic
inequalities in health to widen. In particular, since mortality is
declining, we should expect to observe increasing relative socioeconomic
differences in mortality rates. This is so because generally a reduction
in adverse outcomes tends to increasingly concentrate them in the most
susceptible segments of the overall population, and disadvantaged groups
comprise larger proportions of each increasingly more susceptible segment
of the overall population. A corollary to this increased concentration is an increase in the relative differences in experiencing the adverse
outcome. On the other hand, as mortality declines, we should expect to
observe decreasing differences in survival rates, a function of the fact
that as an outcome declines, disadvantaged groups will tend to comprise a
higher proportion of the population that is now enabled to avoid the
outcome than it did of the population previously avoiding the outcome.4-8
Yet the tendency whereby declines in the prevalence of an outcome
tend to increase relative differences in experiencing the outcome is only
clearly evident as to dichotomous variables. For example, since the
average length of hospital stays among diabetics is generally decreasing,
we should expect to see an increase in the relative difference between the
rates at which higher and lower socioeconomic groups stay beyond some
given number of days (though a decrease in the relative difference
between rates at which higher and lower socioeconomic stay fewer than that
given number of days). But whether an overall decline in a continuous
variable like length of hospital stay should similarly lead to an
increasing disparity between the average stays of two groups is not as
clear. The interpretation of whether changes in measures of difference as
to dichotomous variables reflect meaningful changes in the relative health
of two groups is problematic due to the tendency noted above and to the
ways other measures of size of differences as to such variables change
solely as a result of change in prevalence.4,5,8 If measures of
differences between averages of continuous variables do not suffer from
the same interpretative problem as measures of difference as to
dichotomous variables, the former measures may offer a means of
identifying meaningful changes in the size of health inequalities over
time,8 something that health inequalities research so far seems to be
lacking. Hence, the effect of prevalence changes on effects sizes between
average of continuous variables is a subject warranting study.
References
1. Icks A, Haastert B, Rathmann W, et al. Trends in hospitalization
and sociodemographic factors in diabetic and nondiabetic populations in
Germany: National Health Survey, 1990-1992 and 1998. Am J Public Health.
2006;96:xxx-xxx.doi.10.2105/ALPH.2005.063339.
2. Marmot M, Bobak M. International comparators and poverty and
health in Europe. BMJ. 2000;321:1125-1128.
3. Mackenbach JP, Bakker MJ, for the European Network on
Interventions and Policy to Reduce Inequalities in Health. Tackling
socioeconomic inequalities in health: analysis of European experiences.
Lancet. 2003;362:1409-1414.
4. Scanlan JP. Can we actually measure health disparities? Chance.
2006;19(2):47-51. In press.
5. Scanlan JP. Measuring health disparities. J Public Health Manag
Pract 2006;12(3):294 [Lttr]:
http://www.nursingcenter.com/library/JournalArticle.asp?Article_ID=641470.
6. Scanlan JP. Race and mortality. Society. 2000;37(2):19-35:
http://www.jpscanlan.com/images/Race_and_Mortality.pdf.
7. Scanlan JP. Divining difference. Chance. 1994;7:38-39,48.
8. Scanlan JP. Measuring health inequalities. Paper presented at:
5th International Conference on Health Economics, Management and Policy,
June 5-7, 2006, Athens, Greece:
http://www.jpscanlan.com/images/Measuring_Health_Inequalities.pdf.